The Effect of Terlipressin on Recovery of Liver Function After Hepatectomy

Clinical trial NCT04221672 · UNKNOWN

Trial details

NCT number: NCT04221672
Sponsor: Shanghai Zhongshan Hospital
Status: UNKNOWN
Phase: Phase 3
Study type: INTERVENTIONAL

Terlipressin Adverse Reaction Ascites Hepatic Liver Failure Acute Kidney Injury

Start date: 2019-11-07
Primary completion: 2020-12-30
Enrollment: 86

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.